The store will not work correctly when cookies are disabled.
5-[2-(dimethylamino)ethyl]-2,3-dimethoxy-11-methyl-benzo[c][1,5]benzodiazocine-6,12-dione
ID: ALA4740541
PubChem CID: 162644977
Max Phase: Preclinical
Molecular Formula: C21H25N3O4
Molecular Weight: 383.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc2c(cc1OC)N(CCN(C)C)C(=O)c1ccccc1N(C)C2=O
Standard InChI: InChI=1S/C21H25N3O4/c1-22(2)10-11-24-17-13-19(28-5)18(27-4)12-15(17)20(25)23(3)16-9-7-6-8-14(16)21(24)26/h6-9,12-13H,10-11H2,1-5H3
Standard InChI Key: JXOYMGCFONOFPK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
3.8039 -20.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8027 -21.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5108 -21.8027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5090 -20.1653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6268 -21.9564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8081 -21.9633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2244 -21.3892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2176 -20.5706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7916 -19.9869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6103 -19.9801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1923 -20.5536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2008 -21.3727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9133 -21.7732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6178 -21.3557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6054 -20.5334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8923 -20.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9458 -22.7088 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3943 -22.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5771 -22.6601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1628 -23.3644 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3456 -23.3578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5656 -24.0754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4726 -19.2346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9170 -19.2227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0961 -20.1658 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0959 -19.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0947 -21.8018 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3873 -21.3926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
8 4 2 0
4 1 1 0
12 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
6 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 1 0
9 23 2 0
10 24 1 0
1 25 1 0
25 26 1 0
2 27 1 0
27 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 383.45 | Molecular Weight (Monoisotopic): 383.1845 | AlogP: 2.50 | #Rotatable Bonds: 5 |
Polar Surface Area: 62.32 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.12 | CX LogP: 1.62 | CX LogD: 0.82 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.79 | Np Likeness Score: -0.58 |
References
1. Bieszczad B,Siwek A,Wilczek M,Trzybiński D,Woźniak K,Satała G,Bojarski AJ,Mieczkowski A. (2020) Synthesis, crystal structure and biological activity of novel analogues of tricyclic drugs., 30 (21.0): [PMID:32798652] [10.1016/j.bmcl.2020.127493] |